File Download
Patent History
- ApplicationCN 20031010738 2003-02-28
- PublicationCN 100528238 2009-08-19
Patent Family
Supplementary
-
Citations:
- Appears in Collections:
published patent: Oral DNA combination for treating chronic infection of hepatitis B virus
Title | Oral DNA combination for treating chronic infection of hepatitis B virus |
---|---|
Priority Date | 2002-02-28 US 10/359945P |
Inventors | |
Issue Date | 2009 |
Citation | China Published Patent Application CN 100528238. Beijing, PRC: State Intellectual Property Office (SIPO) of the P.R.C., 2009 How to Cite? |
Abstract | An orally applied DNA composition for improving the damaged immunity associated with chronic infection of HBV and suppressing the transgenic expression in an elongated period contains an attenuated-strain bacteria cell whose target is intestinal muccosa phagocyte for transporting the plasmid carrier which carrys one or more genes coding at least part of HBV protein or peptide, or its complementary DNA. After it comes in the infected host cell, it can clear infection and reverse the immune tolerance state of chronic HBV infection. |
Persistent Identifier | http://hdl.handle.net/10722/176601 |
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2012-11-30T08:38:12Z | - |
dc.date.available | 2012-11-30T08:38:12Z | - |
dc.date.issued | 2009 | - |
dc.identifier.citation | China Published Patent Application CN 100528238. Beijing, PRC: State Intellectual Property Office (SIPO) of the P.R.C., 2009 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/176601 | - |
dc.description.abstract | An orally applied DNA composition for improving the damaged immunity associated with chronic infection of HBV and suppressing the transgenic expression in an elongated period contains an attenuated-strain bacteria cell whose target is intestinal muccosa phagocyte for transporting the plasmid carrier which carrys one or more genes coding at least part of HBV protein or peptide, or its complementary DNA. After it comes in the infected host cell, it can clear infection and reverse the immune tolerance state of chronic HBV infection. | en_HK |
dc.title | Oral DNA combination for treating chronic infection of hepatitis B virus | en_HK |
dc.type | Patent | en_US |
dc.description.nature | published_or_final_version | en_US |
dc.identifier.hkuros | 175104 | - |
dc.contributor.inventor | Wu Wenhan | en_HK |
dc.contributor.inventor | Yuan Guoyong | en_HK |
dc.contributor.inventor | Zheng, B | en_HK |
patents.identifier.application | CN 20031010738 | en_HK |
patents.description.assignee | HONGKONG UNIV [HK] | en_HK |
patents.description.country | China, PRC | en_HK |
patents.date.publication | 2009-08-19 | en_HK |
patents.date.application | 2003-02-28 | en_HK |
patents.date.priority | 2002-02-28 US 10/359945P | en_HK |
patents.description.cc | CN | en_HK |
patents.identifier.publication | CN 100528238 | en_HK |
patents.relation.family | AU 2003210122 (A1) 2003-09-09 | en_HK |
patents.relation.family | CA 2380471 (A1) 2003-08-28 | en_HK |
patents.relation.family | CN 1444996 (A) 2003-10-01 | en_HK |
patents.relation.family | CN 100528238 (C) 2009-08-19 | en_HK |
patents.relation.family | HK 1058144 (A1) 2010-04-23 | en_HK |
patents.relation.family | US 2003162741 (A1) 2003-08-28 | en_HK |
patents.relation.family | US 2006228374 (A1) 2006-10-12 | en_HK |
patents.relation.family | WO 03072012 (A2) 2003-09-04 | en_HK |
patents.description.kind | C | en_HK |
patents.type | Patent_published | en_HK |